drugset
Drugs / Comparator QIV
last change Nov 2024 re-read 2 minutes ago

Comparator QIV

also known as Afluria Quadrivalent · Afluria Quad · Afluria Tetra · S-IIV4 · Seqirus IIV4

Vaccine

Developed for
influenza
Investigated by
ModernaTX, Inc. · Seqirus

Trials 2 · a red edge is where a trial was stopped

today NCT05330975 · Ph 3 NCT02914275 · Ph 3
2017201820192020202120222023202420252026
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 3 NCT05330975 Apr 2022 → Nov 2024 respiratory syncytial virus infectious disease ModernaTX, Inc. Completed No outcome recorded
Phase 3 NCT02914275 Sep 2016 → Mar 2017 influenza Seqirus Completed No outcome recorded
Also used as a comparator or background therapy in 3 trials
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 3 NCT05044195 Comparator Sep 2021 → Jan 2022 influenza Seqirus Completed No outcome recorded
Phase 3 NCT04074928 Comparator Sep 2019 → Sep 2020 influenza Seqirus Completed No outcome recorded
Phase 3 NCT02545543 Comparator Sep 2015 → Jan 2016 influenza Seqirus Completed No outcome recorded

Evidence & citations 8 cited values

Every value below carries the sentence it was read from. 6 sources stand behind the page.

FieldValueCited text
Known as Comparator QIV ClinicalTrials.gov intervention name — accepted as the source's own label NCT02545543 ↗
2

NCT04074928 ↗

NCT05044195 ↗
Known as Afluria Quad “A staged clinical development program of a quadrivalent vaccine (Seqirus IIV4 [S-IIV4]; Afluria® Quadrivalent/Afluria Quad™/Afluria Tetra™), wherein each vaccine strain is...” PMID 30057283 ↗ Jul 2018
Known as Afluria Quadrivalent “A staged clinical development program of a quadrivalent vaccine (Seqirus IIV4 [S-IIV4]; Afluria® Quadrivalent/Afluria Quad™/Afluria Tetra™), wherein each vaccine strain is...” PMID 30057283 ↗ Jul 2018
1

NCT05330975 ↗
Known as Afluria Tetra “A staged clinical development program of a quadrivalent vaccine (Seqirus IIV4 [S-IIV4]; Afluria® Quadrivalent/Afluria Quad™/Afluria Tetra™), wherein each vaccine strain is...” PMID 30057283 ↗ Jul 2018
Known as S-IIV4 “A staged clinical development program of a quadrivalent vaccine (Seqirus IIV4 [S-IIV4]; Afluria® Quadrivalent/Afluria Quad™/Afluria Tetra™), wherein each vaccine strain is...” PMID 30057283 ↗ Jul 2018
Known as Seqirus IIV4 “A staged clinical development program of a quadrivalent vaccine (Seqirus IIV4 [S-IIV4]; Afluria® Quadrivalent/Afluria Quad™/Afluria Tetra™), wherein each vaccine strain is...” PMID 30057283 ↗ Jul 2018
Modality Vaccine “The US-licensed Comparator QIV, inactivated, split-virion, thimerosal-free, quadrivalent influenza vaccine” NCT02545543 ↗
Route Intramuscular “Preferred sites for intramuscular injection are the anterolateral aspect of the thigh in infants 6 months through 11 months of age, the anterolateral aspect of the thigh (or...” NCT02914275 ↗